Coronavirus (COVID-19)
Information and updates to help clinical and laboratory staff manage the impact of COVID-19
Text version of image
O- 8 days, A- 13 days, B- 9 days, AB- 10 days, O+ 9 days, A+ 10 days, B+ 9 days, AB+ 12 days
Refer to the red cell shortage plan if stocks fall to less than 2 days
Text version of image
O- 1.9 days, A- 1.3 days, B- 1.1days, AB- 1.7 days, O+ 1.2 days, A+ 1.4 days, B+ 1.6 days, AB+ 3.2 days
Refer to the platelet shortage plan if stocks fall to 0.5 days or less
Participation in the clinical trials for convalescent plasma research
RECOVERY: This trial has stopped
Read our 15 January communication
REMAP-CAP: This trial is paused and is entering into the data analysis phase
Blood supply updates
22 February 2021
- Intelligence to support demand forecasting
- Stock management
- Maintaining supply of blood components
20 January 2021
- This communication is to inform you about continuing drive to maximise the collection of high antibody titre CCP
- Please continue to hold on to any unused CCP
Archive
Read our archived updates
Do you or your colleagues want to donate?
Please book an appointment by
- Using the Give Blood app
- Booking online
- Telephone 0300 123 23 23
Please be aware of the changes to testing and referring for:
Updates relating to:
- TAS - clinical and operational
- Stem cells - NICE rapid guidance on haemopoietic stem cell transplantation
Survey of blood component requirements in COVID-19 patients
The aim of the survey is to establish levels of blood component use by swab positive COVID-19 patients admitted to hospital.
National Blood Transfusion Committee
- Advice on good stock management
- COVID-19 and transfusion
- FAQ part 1 for hospital labs
- FAQ part 2 for hospital labs